metabolic-diseases

Amylin analogs are in clinical trials to address metabolic diseases on their own as well as to enhance the effects of GLP-1 drugs. The post Amylin analogs in the clinic: a deep dive appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited…